Prab: CSV import

2025-03-17T21:48:44Z

CSV import

← Older revision		Revision as of 21:48, 17 March 2025
Line 34:		Line 34:
	[[Category:Congenital muscular dystrophies]]		[[Category:Congenital muscular dystrophies]]
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T19:49:09Z

CSV import

← Older revision		Revision as of 19:49, 10 February 2025
Line 33:		Line 33:
	[[Category:Genetic disorders]]		[[Category:Genetic disorders]]
	[[Category:Congenital muscular dystrophies]]		[[Category:Congenital muscular dystrophies]]
			{{No image}}

Prab: CSV import

2024-12-02T05:28:39Z

CSV import

New page

POMGNT1

'''POMGNT1''' (Protein O-linked mannose beta-1,2-N-acetylglucosaminyltransferase 1) is an enzyme encoded by the '''POMGNT1''' gene in humans. This enzyme is crucial in the post-translational modification of proteins, specifically in the glycosylation process, where it adds N-acetylglucosamine to O-linked mannose residues on proteins. This modification is essential for the proper function of certain proteins, particularly those involved in muscle and brain development.

==Function==
POMGNT1 is a glycosyltransferase enzyme that catalyzes the transfer of N-acetylglucosamine (GlcNAc) to O-linked mannose residues on proteins. This process is a part of the O-mannosylation pathway, which is critical for the proper folding, stability, and function of glycoproteins. The enzyme is primarily active in the Golgi apparatus, where it modifies proteins destined for the cell surface or secretion.

==Clinical Significance==
Mutations in the '''POMGNT1''' gene are associated with a group of congenital muscular dystrophies known as [[Muscle-Eye-Brain disease]] (MEB) and [[Walker-Warburg syndrome]] (WWS). These conditions are characterized by severe muscle weakness, eye abnormalities, and brain malformations. The lack of proper glycosylation due to POMGNT1 mutations leads to defective protein function, contributing to the symptoms observed in these disorders.

===Muscle-Eye-Brain Disease===
[[Muscle-Eye-Brain disease]] is a rare genetic disorder that affects muscle development, eye formation, and brain structure. Patients with MEB often present with hypotonia, developmental delay, and ocular abnormalities. The disease is inherited in an autosomal recessive pattern, and mutations in the '''POMGNT1''' gene are one of the known genetic causes.

===Walker-Warburg Syndrome===
[[Walker-Warburg syndrome]] is a severe form of congenital muscular dystrophy that also involves brain and eye abnormalities. It is one of the most severe forms of dystroglycanopathy, often leading to early death. Mutations in the '''POMGNT1''' gene disrupt the glycosylation of alpha-dystroglycan, a protein critical for muscle and brain development.

==Genetics==
The '''POMGNT1''' gene is located on chromosome 1p34.1. It consists of multiple exons and encodes a protein that is approximately 660 amino acids in length. The gene is expressed in various tissues, with higher expression levels in the brain and muscle tissues.

==Research and Therapeutic Approaches==
Research into POMGNT1 and its associated pathways is ongoing, with the aim of developing therapeutic strategies to treat conditions like MEB and WWS. Approaches include gene therapy, enzyme replacement therapy, and small molecule drugs that can enhance residual enzyme activity or compensate for the loss of function.

==Also see==
* [[Glycosylation]]
* [[Congenital muscular dystrophy]]
* [[Dystroglycanopathy]]
* [[Golgi apparatus]]

{{Congenital muscular dystrophy}}
{{Glycosyltransferases}}

[[Category:Enzymes]]
[[Category:Genetic disorders]]
[[Category:Congenital muscular dystrophies]]

POMGNT1 - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import